These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 8874346)
1. Clinical experience with oral methadone administration in the treatment of pain in 196 advanced cancer patients. De Conno F; Groff L; Brunelli C; Zecca E; Ventafridda V; Ripamonti C J Clin Oncol; 1996 Oct; 14(10):2836-42. PubMed ID: 8874346 [TBL] [Abstract][Full Text] [Related]
2. Methadone versus morphine as a first-line strong opioid for cancer pain: a randomized, double-blind study. Bruera E; Palmer JL; Bosnjak S; Rico MA; Moyano J; Sweeney C; Strasser F; Willey J; Bertolino M; Mathias C; Spruyt O; Fisch MJ J Clin Oncol; 2004 Jan; 22(1):185-92. PubMed ID: 14701781 [TBL] [Abstract][Full Text] [Related]
3. Switching from morphine to methadone to improve analgesia and tolerability in cancer patients: a prospective study. Mercadante S; Casuccio A; Fulfaro F; Groff L; Boffi R; Villari P; Gebbia V; Ripamonti C J Clin Oncol; 2001 Jun; 19(11):2898-904. PubMed ID: 11387363 [TBL] [Abstract][Full Text] [Related]
4. Opioid switching from transdermal fentanyl to oral methadone in patients with cancer pain. Benítez-Rosario MA; Feria M; Salinas-Martín A; Martínez-Castillo LP; Martín-Ortega JJ Cancer; 2004 Dec; 101(12):2866-73. PubMed ID: 15529307 [TBL] [Abstract][Full Text] [Related]
5. Patient-controlled analgesia with oral methadone in cancer pain: preliminary report. Mercadante S; Sapio M; Serretta R; Caligara M Ann Oncol; 1996 Aug; 7(6):613-7. PubMed ID: 8879376 [TBL] [Abstract][Full Text] [Related]
6. Multicenter, open-label, prospective evaluation of the conversion from previous opioid analgesics to extended-release hydromorphone hydrochloride administered every 24 hours to patients with persistent moderate to severe pain. Weinstein SM; Shi M; Buckley BJ; Kwarcinski MA Clin Ther; 2006 Jan; 28(1):86-98. PubMed ID: 16490582 [TBL] [Abstract][Full Text] [Related]
7. Morphine versus methadone in the pain treatment of advanced-cancer patients followed up at home. Mercadante S; Casuccio A; Agnello A; Serretta R; Calderone L; Barresi L J Clin Oncol; 1998 Nov; 16(11):3656-61. PubMed ID: 9817288 [TBL] [Abstract][Full Text] [Related]
9. The role of methadone in cancer pain treatment--a review. Leppert W Int J Clin Pract; 2009 Jul; 63(7):1095-109. PubMed ID: 19570126 [TBL] [Abstract][Full Text] [Related]
10. Intermittent subcutaneous methadone administration in the management of cancer pain. Centeno C; Vara F J Pain Palliat Care Pharmacother; 2005; 19(2):7-12. PubMed ID: 16061456 [TBL] [Abstract][Full Text] [Related]
11. Opioid plasma concentrations during a switch from transdermal fentanyl to methadone. Mercadante S; Villari P; Ferrera P; Casuccio A; Gambaro V J Palliat Med; 2007 Apr; 10(2):338-44. PubMed ID: 17472504 [TBL] [Abstract][Full Text] [Related]
12. An ad libitum schedule for conversion of morphine to methadone in advanced cancer patients: an open uncontrolled prospective study in a Chinese population. Tse DM; Sham MM; Ng DK; Ma HM Palliat Med; 2003 Mar; 17(2):206-11. PubMed ID: 12701853 [TBL] [Abstract][Full Text] [Related]
13. Efficacy and Safety of Methadone as a Second-Line Opioid for Cancer Pain in an Outpatient Clinic: A Prospective Open-Label Study. Porta-Sales J; Garzón-Rodríguez C; Villavicencio-Chávez C; Llorens-Torromé S; González-Barboteo J Oncologist; 2016 Aug; 21(8):981-7. PubMed ID: 27306912 [TBL] [Abstract][Full Text] [Related]
14. Equianalgesic dose/ratio between methadone and other opioid agonists in cancer pain: comparison of two clinical experiences. Ripamonti C; De Conno F; Groff L; Belzile M; Pereira J; Hanson J; Bruera E Ann Oncol; 1998 Jan; 9(1):79-83. PubMed ID: 9541687 [TBL] [Abstract][Full Text] [Related]
15. Opioid rotation in patients with cancer pain. A retrospective comparison of dose ratios between methadone, hydromorphone, and morphine. Bruera E; Pereira J; Watanabe S; Belzile M; Kuehn N; Hanson J Cancer; 1996 Aug; 78(4):852-7. PubMed ID: 8756381 [TBL] [Abstract][Full Text] [Related]
16. [Treating hospitalized children in severe pain with oral methadone]. Shir Y; Shvelzon V; Rosen G Harefuah; 1998 Mar; 134(6):438-41, 503. PubMed ID: 10909571 [TBL] [Abstract][Full Text] [Related]
17. Switching from morphine to oral methadone in treating cancer pain: what is the equianalgesic dose ratio? Ripamonti C; Groff L; Brunelli C; Polastri D; Stavrakis A; De Conno F J Clin Oncol; 1998 Oct; 16(10):3216-21. PubMed ID: 9779694 [TBL] [Abstract][Full Text] [Related]
18. The role of methadone in cancer-induced bone pain: a retrospective cohort study. Sulistio M; Wojnar R; Key S; Kwok J; Al-Rubaie Z; Michael N Support Care Cancer; 2021 Mar; 29(3):1327-1335. PubMed ID: 32627056 [TBL] [Abstract][Full Text] [Related]
19. Intravenous ketamine infusion as an adjuvant to morphine in a 2-year-old with severe cancer pain from metastatic neuroblastoma. Tsui BC; Davies D; Desai S; Malherbe S J Pediatr Hematol Oncol; 2004 Oct; 26(10):678-80. PubMed ID: 15454842 [TBL] [Abstract][Full Text] [Related]
20. Opioid-induced or pain relief-reduced symptoms in advanced cancer patients? Mercadante S; Villari P; Ferrera P; Casuccio A Eur J Pain; 2006 Feb; 10(2):153-9. PubMed ID: 16310719 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]